CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.05%)
As of: Oct 21, 2026 · 10:56 AM EDT

CASI Pharmaceuticals (CASIF) Finished Goods (2024 - 2025)

Updated

CASI Pharmaceuticals (CASIF) recorded Finished Goods of $840,000 in Q4 2025, down 84.0% from $5.25 million a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Finished Goods (2024 - 2025) Analysis & Trends

  • Across earlier years, Finished Goods came in at $5.25 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CASI Pharmaceuticals 1.86 Mn -18.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 840,000.00
Dec 31, 2024 5.25 Mn
API Access

CASI Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=CASIF&period=max&api_key=YOUR_API_KEY